CellSource Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3423580004
JPY
390.00
17 (4.56%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jan'26
Oct'25
Jul'25
Apr'25
Jan'25
Oct'24
Jul'24
Net Sales
860.02
893.36
997.59
971.32
849.19
1,013.68
1,113.71
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
860.02
893.36
997.59
971.32
849.19
1,013.68
1,113.71
Raw Material Cost
350.70
402.89
421.95
415.79
383.34
716.15
418.72
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.29
0.24
0.51
0.27
0.29
0.31
0.33
Selling and Distribution Expenses
449.68
447.12
469.35
476.28
528.01
556.50
588.34
Other Expenses
-0.03
-0.02
-0.05
-0.03
-0.03
-0.03
-0.03
Total Expenditure (Excl Depreciation)
800.38
850.01
891.31
892.08
911.35
1,272.65
1,007.06
Operating Profit (PBDIT) excl Other Income
59.6
43.4
106.30000000000001
79.2
-62.199999999999996
-259
106.7
Other Income
-2.19
-19.09
2.32
-1.34
0.72
0.26
1.12
Operating Profit (PBDIT)
101.17
80.39
157.94
124.09
-8.79
-206.75
141.77
Interest
0.29
0.24
0.51
0.27
0.29
0.31
0.33
Exceptional Items
-6.24
-47.94
2.60
2.82
4.36
4.60
2.15
Gross Profit (PBDT)
509.31
490.47
575.64
555.52
465.85
297.53
694.99
Depreciation
43.73
56.13
49.34
46.18
52.66
51.96
34.00
Profit Before Tax
50.90
-23.91
110.69
80.45
-57.38
-254.42
109.59
Tax
17.28
51.70
35.58
23.81
-11.91
-118.15
35.36
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
33.62
-75.62
75.10
56.64
-45.46
-136.27
74.23
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
33.62
-75.62
75.10
56.64
-45.46
-136.27
74.23
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
33.62
-75.62
75.10
56.64
-45.46
-136.27
74.23
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
5,950.81
6,016.83
6,094.11
5,947.64
5,893.93
6,037.10
6,170.49
Earnings per share (EPS)
1.69
-3.82
3.78
2.86
-2.3
-6.88
3.73
Diluted Earnings per share
1.69
-3.82
3.78
2.86
-2.3
-6.88
3.73
Operating Profit Margin (Excl OI)
6.93%
4.85%
10.65%
8.16%
-7.32%
-25.55%
9.58%
Gross Profit Margin
11.0%
3.61%
16.04%
13.04%
-0.56%
-19.97%
12.89%
PAT Margin
3.91%
-8.46%
7.53%
5.83%
-5.35%
-13.44%
6.67%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jan 2026 is -3.74% vs -10.45% in Oct 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jan 2026 is 144.44% vs -200.67% in Oct 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jan 2026 is 3.92% vs -36.05% in Oct 2025

stock-summary

Interest

QoQ Growth in quarter ended Jan 2026 is 50.00% vs -60.00% in Oct 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jan 2026 has improved from Oct 2025

Compare Quarterly Results Of CellSource Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
860.02
14,709.47
-13,849.45
-94.15%
Other Operating Income
0.00
0.00
0.00
Total Operating income
860.02
14,709.47
-13,849.45
-94.15%
Raw Material Cost
350.70
11,472.86
-11,122.16
-96.94%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.29
26.66
-26.37
-98.91%
Selling and Distribution Expenses
449.68
2,005.99
-1,556.31
-77.58%
Other Expenses
-0.03
-2.67
2.64
98.88%
Total Expenditure (Excl Depreciation)
800.38
13,478.86
-12,678.48
-94.06%
Operating Profit (PBDIT) excl Other Income
59.63
1,230.61
-1,170.98
-95.15%
Other Income
-2.19
14.49
-16.68
-115.11%
Operating Profit (PBDIT)
101.17
1,506.86
-1,405.69
-93.29%
Interest
0.29
26.66
-26.37
-98.91%
Exceptional Items
-6.24
0.00
-6.24
Gross Profit (PBDT)
509.31
3,236.61
-2,727.30
-84.26%
Depreciation
43.73
261.75
-218.02
-83.29%
Profit Before Tax
50.90
1,159.76
-1,108.86
-95.61%
Tax
17.28
384.95
-367.67
-95.51%
Provisions and contingencies
0
0
0.00
Profit After Tax
33.62
745.23
-711.61
-95.49%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
33.62
745.23
-711.61
-95.49%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
29.59
-29.59
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
33.62
774.82
-741.20
-95.66%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
5,950.81
14,443.28
-8,492.47
-58.80%
Earnings per share (EPS)
1.69
12.32
-10.63
-86.28%
Diluted Earnings per share
1.69
12.32
-10.63
-86.28%
Operating Profit Margin (Excl OI)
6.93%
8.37%
0.00
-1.44%
Gross Profit Margin
11.00%
9.66%
0.00
1.34%
PAT Margin
3.91%
5.07%
0.00
-1.16%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 86.00 Million
in Jan 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jan 2026 is -3.74% vs -10.45% in Oct 2025

stock-summary

YoY Growth in quarter ended Jan 2026 is 1.27% vs -27.64% in Jan 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.36 Million
in Jan 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jan 2026 is 144.44% vs -200.67% in Oct 2025

stock-summary

YoY Growth in quarter ended Jan 2026 is 173.85% vs -131.62% in Jan 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.34 Million
in Jan 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jan 2026 is 3.92% vs -36.05% in Oct 2025

stock-summary

YoY Growth in quarter ended Jan 2026 is 1,188.42% vs -104.10% in Jan 2025

Quarterly - Interest
Interest 0.03 Million
in Jan 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jan 2026 is 50.00% vs -60.00% in Oct 2025

stock-summary

YoY Growth in quarter ended Jan 2026 is 0.00% vs -25.00% in Jan 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.93%
in Jan 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jan 2026 has improved from Oct 2025

stock-summary

YoY Growth in quarter ended Jan 2026 has improved from Jan 2025